Home / TfR (Transferrin R) / Human sTfR Quantikine IVD ELISA Kit

Human sTfR Quantikine IVD ELISA Kit

Catalog #: DTFR1
23 Citations 1 Review Datasheet / COA / SDS
This product has been discontinued

Discontinued Product

DTFR1 has been discontinued.
View all TfR (Transferrin R) products.
Human TfR (Transferrin R) In Vitro Diagnostic ELISA Standard Curve
2 Images
Product Details
Procedure
Citations (23)
FAQs
Reviews (1)
Summary Precision Recovery Linearity Data Examples Product Datasheets Preparation and Storage Background Related Research Areas

Human sTfR Quantikine IVD ELISA Kit Summary

Assay Type
Solid Phase Sandwich ELISA
Format
96-well strip plate
Assay Length
2.5 hours
Sample Type & Volume Required Per Well
Serum (20 uL), EDTA Plasma (20 uL), Heparin Plasma (20 uL), Citrate Plasma (20 uL)
Sensitivity
0.5 nmol/L
Assay Range
3.0 - 80 nmol/L (Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma)
Specificity
Measures human sTfR levels in various samples
Cross-reactivity
< 0.5% cross-reactivity observed with available related molecules.Cross-species reactivity not tested.
Interference
Interference observed with other substances.

Product Summary

The Quantikine IVD Human sTfR Immunoassay is designed for the quantitative determination of soluble transferrin receptor (sTfR) concentrations in human serum and plasma as an aid in the diagnosis of Iron-Deficiency Anemia (IDA), especially for the differential diagnosis of IDA and Anemia of Chronic Disease (ACD). For In Vitro Diagnostic Use.

Precision

Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested on one plate to assess intra-assay precision
Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision

Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma

Intra-Assay Precision Inter-Assay Precision
Sample 1 2 3 1 2 3
n 20 20 20 60 60 60
Mean (nmol/L) 6.9 18.2 40.2 10.9 25.7 67.2
Standard Deviation 0.3 1.3 2.5 0.7 1.4 3.8
CV% 4.3 7.1 6.2 6.4 5.4 5.7

Recovery

The recovery of sTfR spiked to three different levels throughout the range of the assay in various matrices was evaluated.

Sample Type Average % Recovery Range %
Citrate Plasma (n=5) 112 105-121
EDTA Plasma (n=5) 103 97-112
Heparin Plasma (n=5) 106 101-112
Serum (n=5) 97 95-100

Linearity

To assess the linearity of the assay, five samples containing high concentrations of sTfR were diluted with Specimen Diluent and evaluated.
Human TfR (Transferrin R) In Vitro Diagnostic ELISA Linearity

Scientific Data

N/A Human TfR (Transferrin R) In Vitro Diagnostic ELISA Standard Curve View Larger

Human TfR (Transferrin R) In Vitro Diagnostic ELISA Standard Curve

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Preparation and Storage

Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: TfR (Transferrin R)

Transferrin receptors are transmembrane, homodimeric proteins that play a role in iron transport, uptake, and storage. TfR is an essential receptor, found on almost all cell types, regulated by intracellular iron concentration, and has a high affiinity for transferrin. Soluble TfR (sTfR) arises from the proteolysis of TfR into monomers that can be measured in plasma and serum. TfR2 has limited tissue distribution (hepatocytes and enterocytes), is regulated by the cell cycle, and binds transferrin poorly.

Long Name:
Transferrin Receptor
Entrez Gene IDs:
7037 (Human); 22042 (Mouse); 64678 (Rat)
Alternate Names:
CD71 antigen; CD71; CD71TRFR; p90; T9; TfR (Transferrin R); TfR (TransferrinR); TfR; TFR1; TFRC; TR; transferrin receptor (p90, CD71); transferrin receptor protein 1; TRFR

Assay Procedure

Refer to the product datasheet for the complete assay procedure.

Bring all reagents and samples to room temperature before use. It is recommended that all samples, standards, and controls be assayed in duplicate.

  1. Prepare all reagents, standard dilutions, and samples as directed in the product insert.
  2. Remove excess microplate strips from the plate frame, return them to the foil pouch containing the desiccant pack, and reseal.

    3. 100 µL Assay Diluent


    assay procedure
  3. Add 100 µL of Assay Diluent to each well.

    4. 20 µL Standard, Control, or Sample


    assay procedure
  4. Add 20 µL of Standard, control, or sample to each well. Cover with a plate sealer, and incubate at room temperature for 1 hour.
  5. Aspirate each well and wash, repeating the process 3 times for a total of 4 washes.

    6. 100 µL Conjugate


    assay procedure
  6. Add 100 µL of Conjugate to each well. Cover with a new plate sealer, and incubate at room temperature for 1 hour.
  7. Aspirate and wash 4 times.

    8. 100 µL Substrate Solution


    assay procedure substrate solution
  8. Add 100 µL Substrate Solution to each well. Incubate at room temperature for 30 minutes. PROTECT FROM LIGHT.

    9. 100 µL Stop Solution


    assay procedure stop solution
  9. Add 100 µL of Stop Solution to each well. Read at 450 nm within 30 minutes. Set wavelength correction to 540 nm or 570 nm.

Citations for Human sTfR Quantikine IVD ELISA Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

23 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study
    Authors: K Wray, A Allen, E Evans, C Fisher, A Premawardh, L Perera, R Rodrigo, G Goonathila, L Ramees, C Webster, AE Armitage, AM Prentice, DJ Weatherall, H Drakesmith, SR Pasricha
    Am. J. Hematol, 2017-02-01;92(2):196-203.
    Species: Human
    Sample Types: Serum
  2. The effects of fat loss after bariatric surgery on inflammation, serum hepcidin, and iron absorption: a prospective 6-mo iron stable isotope study.
    Authors: Cepeda-Lopez A, Allende-Labastida J, Melse-Boonstra A, Osendarp S, Herter-Aeberli I, Moretti D, Rodriguez-Lastra R, Gonzalez-Salazar F, Villalpando S, Zimmermann M
    Am J Clin Nutr, 2016-08-24;104(4):1030-1038.
    Species: Human
    Sample Types: Serum
  3. Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease?
    Authors: E Lukaszyk, M Lukaszyk, E Koc-Zoraws, A Bodzenta-L, J Malyszko
    Arch Med Sci, 2016-03-17;13(4):845-850.
    Species: Human
    Sample Types: Serum
  4. The impact of maternal obesity on iron status, placental transferrin receptor expression and hepcidin expression in human pregnancy.
    Authors: Garcia-Valdes L, Campoy C, Hayes H, Florido J, Rusanova I, Miranda M, McArdle H
    Int J Obes (Lond), 2015-01-23;39(4):571-8.
    Species: Human
    Sample Types: Serum
  5. Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study.
    Authors: McDermid, Joann M, Hennig, Branwen, van der Sande, Marianne, Hill, Adrian V, Whittle, Hilton C, Jaye, Assan, Prentice, Andrew M
    BMC Infect Dis, 2013-01-29;13(0):48.
    Species: Human
    Sample Types: Plasma
  6. Regulation of hepcidin expression at high altitude.
    Authors: Talbot NP, Lakhal S, Smith TG, Privat C, Nickol AH, Rivera-Ch M, Leon-Velarde F, Dorrington KL, Mole DR, Robbins PA
    Blood, 2011-11-30;119(3):857-60.
    Species: Human
    Sample Types: Plasma
  7. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.
    Authors: Piperno A, Galimberti S, Mariani R
    Blood, 2010-12-13;117(10):2953-9.
    Species: Human
    Sample Types: Serum
  8. Comparison between one and three doses a week of recombinant erythropoietin in very low birth weight infants.
    Authors: Vazquez Lopez MA, Llamas MA, Galera R, Sanchez AR, Lendinez F, Gonzalez-Ripoll M, Diez J, Bonillo A
    J Perinatol, 2010-08-05;31(0):118-24.
    Species: Human
    Sample Types: Serum
  9. Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation.
    Authors: Karl JP, Lieberman HR, Cable SJ, Williams KW, Young AJ, McClung JP
    Am. J. Clin. Nutr., 2010-05-05;92(1):93-100.
    Species: Human
    Sample Types: Serum
  10. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis.
    Authors: Bateman AP, McArdle F, Walsh TS
    Crit. Care Med., 2009-06-01;37(6):1906-12.
    Species: Human
    Sample Types: Serum
  11. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction.
    Authors: McDermid JM, van der Loeff MF, Jaye A, Hennig BJ, Bates C, Todd J, Sirugo G, Hill AV, Whittle HC, Prentice AM
    Am. J. Clin. Nutr., 2009-05-27;90(1):225-33.
    Species: Human
    Sample Types: Plasma
  12. Randomized, double-blind, placebo-controlled trial of iron supplementation in female soldiers during military training: effects on iron status, physical performance, and mood.
    Authors: McClung JP, Karl JP, Cable SJ, Williams KW, Nindl BC, Young AJ, Lieberman HR
    Am. J. Clin. Nutr., 2009-05-27;90(1):124-31.
    Species: Human
    Sample Types: Serum
  13. Body iron excretion by healthy men and women.
    Authors: Hunt JR, Zito CA, Johnson LK
    Am. J. Clin. Nutr., 2009-04-22;89(6):1792-8.
    Species: Human
    Sample Types: Serum
  14. Excessive body iron stores are not associated with risk of coronary heart disease in women.
    Authors: Sun Q, Ma J, Rifai N, Franco OH, Rexrode KM, Hu FB
    J. Nutr., 2008-12-01;138(12):2436-41.
    Species: Human
    Sample Types: Plasma
  15. Retinol and riboflavin supplementation decreases the prevalence of anemia in chinese pregnant women taking iron and folic Acid supplements.
    Authors: Ma AG, Schouten EG, Zhang FZ, Kok FJ, Yang F, Jiang DC, Sun YY, Han XX
    J. Nutr., 2008-10-01;138(10):1946-50.
    Species: Human
    Sample Types: Plasma
  16. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children.
    Authors: Atkinson SH, Rockett KA, Morgan G, Bejon PA, Sirugo G, O'Connell MA, Hanchard N, Kwiatkowski DP, Prentice AM
    Blood, 2008-08-20;112(10):4276-83.
    Species: Human
    Sample Types: Plasma
  17. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
    Authors: Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, Moroney JW, Reed CH, Luban NL, Wang RH, Eling TE, Childs R, Ganz T, Leitman SF, Fucharoen S, Miller JL
    Nat. Med., 2007-08-26;13(9):1096-101.
    Species: Human
    Sample Types: Serum
  18. Electrolytic iron or ferrous sulfate increase body iron in women with moderate to low iron stores.
    Authors: Swain JH, Johnson LK, Hunt JR
    J. Nutr., 2007-03-01;137(3):620-7.
    Species: Human
    Sample Types: Serum
  19. Lung injury after ozone exposure is iron dependent.
    Authors: Ghio AJ, Turi JL, Madden MC, Dailey LA, Richards JD, Stonehuerner JG, Morgan DL, Singleton S, Garrick LM, Garrick MD
    Am. J. Physiol. Lung Cell Mol. Physiol., 2006-08-11;292(1):L134-43.
    Species: Human
    Sample Types: BALF
  20. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Authors: Chen YC, Hung SC, Tarng DC
    Am. J. Kidney Dis., 2006-06-01;47(6):1036-44.
    Species: Human
    Sample Types: Serum
  21. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis.
    Authors: Fitzsimons EJ, Houston T, Munro R, Sturrock RD, Speekenbrink AB, Brock JH
    Arthritis Rheum., 2002-04-15;47(2):166-71.
    Species: Human
    Sample Types: Serum
  22. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults.
    Authors: Shalev H, H÷Û beta l®ð, Kapleushnik Y, =Å|JuacïÐ, Haeskelzon L, Degani O, Kransnov T, Sphilberg O, Moser A, Yaniv I, Tamary H
    ˆ9—s_àݺó<bz¸ƒÑŸþ鿵, 2002-03-01;68(3):170-4.
    Species: Human
    Sample Types: Serum
  23. Evaluation of tumor necrosis factor-alpha and erythropoietin serum levels in B-cell chronic lymphocytic leukemia patients with anemia.
    Authors: Capalbo S, Battista C, Delia M, Ciancio A, De Santis G, Dargenio M, Diomede D, Liso V
    Acta Haematol., 2002-01-01;108(2):84-9.
    Species: Human
    Sample Types: Serum

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs

Reviews for Human sTfR Quantikine IVD ELISA Kit

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human sTfR Quantikine IVD ELISA Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human sTfR Quantikine IVD ELISA Kit
By Prakasha Kempaiah on 06/03/2016
Sample Tested: Serum